World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 27 March 2023
Main ID:  NCT02971358
Date of registration: 20/11/2016
Prospective Registration: No
Primary sponsor: Medical University of Vienna
Public title: Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer
Scientific title: Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer - a Prospective Single Center Phase I/II Study
Date of first enrolment: August 2016
Target sample size: 200
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02971358
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Austria
Contacts
Name:     Bernhard Grubmüller, MD
Address: 
Telephone: 004314040026150
Email: bernhard.grubmueller@meduniwien.ac.at
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Adenocarcinoma of the prostate

- Very high risk PCA (PSA = 20 oder Gleason Score = 8 oder = cT3) and/or
oligometastasierte PCA (T any N positive M any, oder T any N any M positive)

- =5 bone metastasis

- =75 years

- Ability for informed consent

- Clinically no infiltration into the rectum or pelvic wall

- Clinically no visceral metastasis

- Male, >18 Jahre

- Fit for surgery

- ECOG Performance Status 0 oder 1

Exclusion Criteria:

- Male, < 18 Jahre

- > 5 bone metastasis

- > 75 years

- No ability for informed consent

- Clinically infiltration into the rectum or pelvic wall

- Not fit for surgery

- Clinically visceral metastasis



Age minimum: 18 Years
Age maximum: 75 Years
Gender: Male
Health Condition(s) or Problem(s) studied
Locally Advanced and Metastatic Prostate Cancer
Intervention(s)
Procedure: Radical prostatectomy
Primary Outcome(s)
The rate of perioperative complications within 90 days after surgery (Clavien-Dindo-classification) [Time Frame: 90]
Secondary Outcome(s)
Time to start androgen deprivation therapy [Time Frame: 2 years]
Secondary ID(s)
1461/2016
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history